Onegene Biotechnology is thrilled to announce our CEO, SungJin Park, and members of our Business Development team will be at the upcoming 2023 JP Morgan Healthcare Conference on Jan. 9~12, 2023 in San Francisco.
Meet us and learn more about our multi-specific platform technology, UniStac®, trispecific TME immune activator program (OGB23501), and partnership opportunities.
If you would like to connect with us, please feel free to reach out to SC You, BD Manager at seokchan.you@onegenebt.com.